Exagen Correlations

XGN Stock  USD 3.75  0.13  3.59%   
The current 90-days correlation between Exagen Inc and Fonar is 0.15 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Exagen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Exagen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Exagen Correlation With Market

Significant diversification

The correlation between Exagen Inc and DJI is 0.07 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Exagen Inc and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Exagen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Moving against Exagen Stock

  0.35DRMA Dermata TherapeuticsPairCorr
  0.35DVAX Dynavax TechnologiesPairCorr
  0.33DTIL Precision BioSciences Earnings Call This WeekPairCorr
  0.32VALN Valneva SE ADRPairCorr
  0.61VSTM VerastemPairCorr
  0.47VRNA Verona Pharma PLCPairCorr
  0.46VTGN VistaGen TherapeuticsPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
SHCCSTL
SHCFONR
CSTLFONR
CSTLBNR
SHCBNR
CSTLSERA
  
High negative correlations   
DRIOPMD
PMDSHC
PMDCSTL
DRIOGTH
PMDGTH
SHCGTH

Risk-Adjusted Indicators

There is a big difference between Exagen Stock performing well and Exagen Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Exagen's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
FONR  1.35 (0.07) 0.00 (0.22) 0.00 
 2.50 
 10.83 
BNR  3.85 (0.13) 0.00 (0.34) 0.00 
 8.52 
 26.46 
SERA  3.43 (0.83) 0.00 (0.79) 0.00 
 6.45 
 26.54 
OLK  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
LMDX  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
GTH  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
CSTL  2.46 (0.47) 0.00 (2.19) 0.00 
 4.51 
 23.81 
SHC  1.40 (0.04) 0.00 (0.14) 0.00 
 2.40 
 12.51 
PMD  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
DRIO  6.32  0.56  0.07 (1.44) 8.91 
 11.29 
 121.18 

Exagen Corporate Management

Jeffrey BlackChief OfficerProfile
Debra ZackChief OfficerProfile
John WegenerSenior MarketingProfile
Ryan DouglasInvestors OfficerProfile
Mark HazeltineChief OfficerProfile
MingChou LeeChief OfficerProfile